|
|
![]() | ![]() | ![]() | ![]() |
These excerpts taken from the TMTA 10-K filed Mar 17, 2008. Research
and Development
Costs to develop Transmetas products and licenses are
expensed as incurred in accordance with the SFAS 2,
Accounting for Research and Development
Costs, which establishes accounting and reporting
standards for research and development costs.
Research and Development Costs to develop Transmetas products and licenses are expensed as incurred in accordance with the SFAS 2, Accounting for Research and Development Costs, which establishes accounting and reporting standards for research and development costs. This excerpt taken from the TMTA 10-K filed Mar 30, 2007. Research
and Development
Costs to develop Transmetas products and licenses are
expensed as incurred in accordance with the SFAS 2,
Accounting for Research and Development Costs, which
establishes accounting and reporting standards for research and
development costs.
| EXCERPTS ON THIS PAGE:
RELATED TOPICS for TMTA: |
| |||||||